Genomics

Manipulating Molecules with the LUMICKS Platform

In the famous 1968 short film, “Cosmic Zoom”, the viewer starts with a boy in a boat, and zooms out to the Earth, to the solar system, and to the galaxy, until the viewer gets the entire view of the universe. Halfway through the film, the camera view switches direction and zooms into a mosquito […]

When Will Xenotransplantation of Pig Organs Be Possible?

We recently profiled eight companies creating exotic lab-based foods. Dubbed cellular agriculture, the technology to grow meat from animal cells has advanced swiftly in just a few years. One of the first commercial products just hit the menu at a Singaporean restaurant. At $23 for four chicken nuggets, it’s still more of a novelty than […]

Why is Pacific Biosciences Stock Dropping?

When you start to stick your neck out and draw conclusions based on evidence you present, nobody says anything if you’re right. Crickets. However, if your conclusion turns out to be wrong, people will crawl out of their graves to tell the world what a moron you are. That’s just how it goes around here, […]

Calico Purring Right Along With Life Extension Research

Earlier this month, Alphabet (GOOG) took the air out of its Loon subsidiary, a former moonshot project for deploying internet around the world using high-flying balloons. Apparently, the economics just didn’t work out. No word on how much Google’s parent company spent on Loon, but SoftBank had sunk $125 million into the business in 2019. […]

GenapSys Finally Commercializes Desktop DNA Sequencer

Good things come to those who wait, but we’re an impatient bunch here at Nanalyze. It’s no wonder that we decided to write about disruptive technology rather than spend the time actually creating it. Consider that it took an international team of scientists 13 years and $3 billion to map the genes that comprise the […]

When Are Genetic Health Tests Worth Taking?

Investors in Illumina must be stoked about how things have been going so far for a company that commands a dominant market share in one of the most transformative technologies of our time – genetic sequencing. It’s allowed us to pursue promising technologies like gene editing – and now base editing – which means we can start […]

Centogene: Genetic Testing for Rare Diseases

You probably don’t know much about rare diseases unless you’re one of the unfortunate few who are afflicted by one. Not everyone agrees upon how we ought to define a rare disease, but in the United States, that’s considered one that affects less than 200,000 people or about 1 in 1,636 people. While some diseases […]

9 Genomics Startups for Investors to Watch

The history of direct-to-consumer genomics tests goes something like this. Genomics startups first started offering hereditary tests that required a DNA sample and everyone quickly climbed on board without realizing just how much information they were handing over to people they didn’t really know that well. Eventually, testing companies started moving into DNA health tests and then the FDA […]

The 10X Genomics IPO and Single-Cell Sequencing

Over the last few weeks, pundits have been tearing apart the WeWork Initial Public Offering (IPO), and uncovering all kinds of things to write about. It’s a company that’s raised some eyebrows because of their burn rate (between $150 – 200 million a month) and the company’s vague business model which some have described as […]

Are Dog DNA Tests Worth the Hype?

It’s a dog-eat-dog world when it comes to DNA testing. We’ve seen it all over the last few years, from serious topics such as privacy issues and the ethics of DNA testing for intelligence to super silly applications like physical fitness and dating. It’s certainly an industry that has courted its share of controversy, with companies […]